Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PRCT

PRCT - PROCEPT BioRobotics Corporation Stock Price, Fair Value and News

$30.03-0.75 (-2.44%)
Market Closed

58/100

PRCT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

58/100

PRCT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$31.05

Target 3M

$29.6

Target 6M

$30.09

PRCT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PRCT Price Action

Last 7 days

-3.0%

Last 30 days

-6.6%

Last 90 days

-12.6%

Trailing 12 Months

-58.8%

PRCT RSI Chart

PRCT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PRCT Valuation

Market Cap

1.7B

Price/Earnings (Trailing)

-19.84

Price/Sales (Trailing)

5.6

Price/Free Cashflow

-21.05

PRCT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$31.05

Target 3M

$29.6

Target 6M

$30.09

PRCT Fundamentals

PRCT Revenue

Revenue (TTM)

299.9M

Rev. Growth (Yr)

42.76%

Rev. Growth (Qtr)

5.23%

PRCT Earnings

Earnings (TTM)

-84.6M

Earnings Growth (Yr)

-2.08%

Earnings Growth (Qtr)

-9.36%

PRCT Profitability

Operating Margin

64.55%

Return on Equity

-22.24%

Return on Assets

-16.53%

Free Cashflow Yield

-4.75%

PRCT Investor Care

Shares Dilution (1Y)

7.08%

Diluted EPS (TTM)

-1.52

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025249.1M274.9M299.9M0
2024156.3M176.6M199.8M224.5M
202385.2M101.6M116.4M136.2M
202241.5M49.7M61.4M75.0M
202114.4M21.1M27.8M34.5M
20200007.7M
Get all data in R, Python etc through our Historical Stock Data APIs

About PROCEPT BioRobotics Corporation

PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
 CEO
 WEBSITEprocept-biorobotics.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES428

PROCEPT BioRobotics Corporation Frequently Asked Questions

PRCT is the stock ticker symbol of PROCEPT BioRobotics Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of PROCEPT BioRobotics Corporation is 1.68 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check PRCT's fair value in chart for subscribers.

The fair value guage provides a quick view whether PRCT is over valued or under valued. Whether PROCEPT BioRobotics Corporation is cheap or expensive depends on the assumptions which impact PROCEPT BioRobotics Corporation's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PRCT.

As of Wed Jan 28 2026, PRCT's PE ratio (Price to Earnings) is -19.84 and Price to Sales (PS) ratio is 5.6. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRCT PE ratio will change depending on the future growth rate expectations of investors.